"Their commitment strengthens BOOST Pharma’s position as a leader in cell therapy for genetic bone disorders and enables continued progress of BT-101 towards the clinic." "We believe BOOST Pharma’s ...

The group alleges selective use of field trial results to project higher yields and early maturation while ICAR scientists defend the evaluation process as transparent and scientifically sound ...

This policy primer from the Allen Lab for Democracy Renovation is intended to introduce the ideas and conversations around reform of Section 230 of the Communications Decency Act and how it could ...

The presentation will provide two-year follow-up data from the landmark BOOSTB4 Phase I/II clinical study. Notably, the results demonstrate that more than 50% of the treated patients experienced zero ...

If you’re trying to conceive, learning about fertilisation makes the process less of a mystery. It highlights that conception ...

Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type 2I/R9, the company was back at it again, this time reporting positive ...

Dyne Therapeutics, Inc. ((DYN)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

The bridge aims to prevent the extinction of local mountain lions by allowing them to breed with other populations.

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

Ann Angeletti still goes to work six times a week, and has shared the four key things she does in her day-to-day life.

Oct 14 (Reuters) - Britain's Financial Conduct Authority on Tuesday secured $101 million in redress for investors in a fund sub-managed by BlueCrest Capital Management and imposed a public censure on ...

The Trump administration’s embrace of unproven or debunked theories about vaccines and Tylenol has left doctors fielding questions from worried parents. By Gina Kolata and Azeen Ghorayshi The first ...